About

The Lockwood Group offers consulting services to the healthcare and pharmaceutical sectors, focusing on clients in advanced drug development stages. They create strategic publication plans to ensure accurate communication of scientific data while adhering to regulatory standards. Additionally, they provide commercial support during product prelaunch and collaborate with clients to identify market needs. Their medical animation affiliate, Random42, enhances their offerings by making complex scientific information more accessible.

Simplify's Take

What believers are saying

• Increased demand for digital health solutions boosts growth in medical communications.
• Rise of personalized medicine creates opportunities for specialized communication strategies.
• Integration of AI enhances publication strategies and data analysis capabilities.

What critics are saying

• Emerging firms using AI-driven content creation threaten market share.
• Pharmaceutical companies developing in-house teams may reduce demand for external services.
• Tightening EU regulatory standards could increase compliance costs.

What makes The Lockwood Group, LLC unique

• Specializes in healthcare and pharmaceutical sectors, focusing on advanced drug development stages.
• Offers strategic publication plans tailored to specific audiences and regulatory standards.
• Provides commercial support during prelaunch, launch, and post-launch phases.

Help us improve and share your feedback! Did you find this helpful?

YesNo